Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects by Benus, Robin F. J. et al.
  
 University of Groningen
Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in
healthy human subjects
Benus, Robin F. J.; van der Werf, Tjip S.; Welling, Gjalt W.; Judd, Patricia A.; Taylor, Moira
A.; Harmsen, Hermie J. M.; Whelan, Kevin
Published in:
British Journal of Nutrition
DOI:
10.1017/S0007114510001030
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2010
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Benus, R. F. J., van der Werf, T. S., Welling, G. W., Judd, P. A., Taylor, M. A., Harmsen, H. J. M., &
Whelan, K. (2010). Association between Faecalibacterium prausnitzii and dietary fibre in colonic
fermentation in healthy human subjects. British Journal of Nutrition, 104(5), 693-700.
https://doi.org/10.1017/S0007114510001030
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Association between Faecalibacterium prausnitzii and dietary fibre in colonic
fermentation in healthy human subjects
Robin F. J. Benus1,2*, Tjip S. van der Werf2, Gjalt W. Welling1, Patricia A. Judd3, Moira A. Taylor4,
Hermie J. M. Harmsen1 and Kevin Whelan5
1Departments of Medical Microbiology, University Medical Centre Groningen, University of Groningen, Groningen,
The Netherlands
2Internal Medicine, and Pulmonary Diseases and Tuberculosis, Infectious Diseases & Tuberculosis Service, University Medical
Centre Groningen, University of Groningen, Groningen, The Netherlands
3Lancashire School of Health and Postgraduate Medicine, University of Central Lancashire, Preston, UK
4School of Biomedical Sciences, University of Nottingham, Nottingham, UK
5Nutritional Sciences Division, King’s College London, London, UK
(Received 29 September 2009 – Revised 26 January 2010 – Accepted 2 March 2010 – First published online 29 March 2010)
The intestinal microbiota are a complex ecosystem influencing the immunoregulation of the human host, providing protection from colonising
pathogens and producing SCFA as the main energy source of colonocytes. Our objective was to investigate the effect of dietary fibre exclusion
and supplementation on the intestinal microbiota and SCFA concentrations. Faecal samples were obtained from healthy volunteers before and after
two 14 d periods of consuming formulated diets devoid or supplemented with fibre (14 g/l). The faecal microbiota were analysed using fluorescent
in situ hybridisation and SCFA were measured using GLC. There were large and statistically significant reductions in the numbers of the
Faecalibacterium prausnitzii (P#0·01) and Roseburia spp. (P#0·01) groups during both the fibre-free and fibre-supplemented diets. Significant
and strong positive correlations between the proportion of F. prausnitzii and the proportion of butyrate during both baseline normal diets
were found (pre-fibre free r 0·881, P¼0·001; pre-fibre supplemented r 0·844, P¼0·002). A significant correlation was also found between the
proportional reduction in F. prausnitzii and the proportional reduction in faecal butyrate during both the fibre-free (r 0·806; P¼0·005) and the
fibre-supplemented diet (r 0·749; P¼0·013). These findings may contribute to the understanding of the association between fibre, microbiota
and fermentation in health, during enteral nutrition and in disease states such as Crohn’s disease.
Dietary fibre: Bacteria: Anaerobic bacteria: Molecular diagnostic techniques: Microbiota: Fermentation
The intestinal microbiota are a complex ecosystem of several
hundred microbial species(1). The microbiota have numerous
functions in the maintenance of health, including the ability
to decrease colonisation and infection with pathogens, a
mechanism referred to as colonisation resistance(2). The intes-
tinal microbiota also produce SCFA through metabolism of
fermentable substrates such as dietary fibre. SCFA stimulate
colonic water absorption(3) and, in particular butyrate, are the
primary energy source for the colonocytes that constitute the
epithelial lining of the large intestine(4). Butyrate promotes
the growth of colonocytes in animal models, preventing
mucosal atrophy, and appears to lower the risk of malignant
transformation in the colon(5). Therefore, butyrate in the
intestine is beneficial for the integrity of the mucosal barrier
function of the colon. However, not all species of the
intestinal microbiota produce butyrate, with the predominant
butyrate producers belonging to the genus Faecalibacterium
prausnitzii (6) and Roseburia spp.(4).
Colonisation resistance and SCFA production are therefore
important functions of the intestinal microbiota(7). However,
when the intestinal microbiota are altered, for example
through the use of antimicrobials(8) or by a reduction in
fermentable biomass(9), their capacity to exert these important
functions is reduced. The major source of fermentable
biomass is NSP (i.e. dietary fibre). Both the US Institute of
Medicine(10) and the American Dietetic Association(11) have
recommended increased dietary fibre consumption as evidence
accumulates that higher intakes are related to a lower risk
of CVD, and potentially colon cancer, diabetes and obesity.
These beneficial effects of dietary fibre may be mediated
in part by the augmentation of colonic fermentation and
SCFA production.
Research on the impact of dietary fibre on the intestinal
microbiota and SCFA production in human subjects is
impeded by the ubiquitous presence of fibre in the normal
diet, making it difficult to achieve total dietary exclusion.
*Corresponding author: Dr Robin F. J. Benus, fax þ31 503619105, email r.f.j.benus@mmb.umcg.nl
Abbreviation: FISH, fluorescent in situ hybridisation.
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However, one approach to resolving this is through the use of
liquid enteral formulas that are used to provide artificial
nutrition support. To date, many of the most commonly used
standard formulas have been completely devoid of fibre, but
formulas supplemented with various types of dietary fibre
are now available.
Use of such formulas provides a way of investigating the
complete removal of dietary fibre from the diet as well as
the effect of addition of specific types and amounts of dietary
fibre on the intestinal microbiota and SCFA in healthy human
subjects. In addition, they may also enable investigation of
two clinically relevant situations. First, patients receiving
enteral nutrition in the intensive care unit, and other settings,
can experience impairments in gastrointestinal function,
including diarrhoea(12). Second, enteral formula nutrition is
effective in inducing remission in active Crohn’s disease(13).
Alterations of the intestinal microbiota implicated in disease
activity can also be effective in inducing remission(14).
Furthermore, faecal concentrations of F. prausnitzii are
lower in patients with active inflammatory bowel disease(15),
whilst butyrate may be a potential treatment for Crohn’s
disease(16) through its immunoregulatory effects(17).
Our hypothesis is that the exclusion of dietary fibre will
cause a significant change in the numbers of the butyrate
producers F. prausnitzii and Roseburia spp., and thereby
reduce SCFA concentrations; in contrast, the addition of
dietary fibres will prevent such effects on the intestinal
microbiota and SCFA.
We have previously described the effects of consumption of
enteral formulas devoid of fibre on the total microbiota and
SCFA. The reduction of both total bacterial count and SCFA
production that occurred was partially prevented by the addition
of fibre and fructo-oligosaccharides to the diet(18). Interestingly,
butyrate concentrations were reduced following both fibre-free
and fibre-supplemented formulas. However, in that study there
was no extensive analysis of bacterial groups, including the
butyrate producers F. prausnitzii and Roseburia spp., nor was
there analysis of the association between specific bacterial
groups and the concentrations of SCFA.
The majority of bacteria in the colon are anaerobic, many
are hard to culture and enumerating using selective media
typically underestimates the numbers of bacteria in faecal
samples compared with molecular techniques such as fluor-
escent in situ hybridisation (FISH)(19). Our extended probe
set covers approximately 88 % of the total intestinal micro-
biota in healthy volunteers, including the butyrate producers
F. prausnitzii and Roseburia spp.(20).
Here we describe an independent blinded reanalysis of the
faecal samples from the previous study of liquid formulas
devoid of, and supplemented with, fibre(18), using the extended
probe set, in order to provide further insights into the relation-




Samples were obtained from healthy volunteers recruited
to a prospective, double-blinded, randomised, cross-over
trial(18). The subjects were free of gastrointestinal diseases, or
self-reported eating disorders; they were not following a special
diet, had not used antibiotics in the previous 3 months and
had not consumed products containing prebiotics or probiotics
in the previous 1 month. The study was conducted according
to the guidelines laid down in the Declaration of Helsinki and
was approved by the King’s College London Research Ethics
Committee (reference 01-62). Written informed consent was
obtained from each subject before recruitment.
Protocol
Subjects consumed their normal diet for 14 d (baseline period),
then an enteral formula for 14 d (diet period), followed by
their normal diet for 6 weeks as a washout phase (baseline
period) and then an alternative enteral formula again for
14 d (diet period). All consumption of prebiotics and probio-
tics was avoided for the duration of the study. During the
liquid diet periods, the formulas were the only source of nutri-
tion except for water ad libitum and black tea and/or coffee to
a maximum of 600 ml/d. Subjects were advised on the
amounts of formula required to achieve their calculated total
energy expenditure and provided with sufficient formula to
maintain their weight. During the diet periods, subjects con-
sumed either a fibre-free enteral formula or a formula sup-
plemented with dietary fibre (14 g/l). The dietary fibre
formula consisted of pea fibre (8·9 g/l) and fructo-oligosac-
charides (5·1 g/l) and therefore contained 48 % soluble and
52 % insoluble fibre fractions. The nutritional values of both
formulas were almost identical except for the difference in
fibre content. The order of consumption of each formula
was randomised and this randomisation was blinded for both
study subjects and researchers. This blinding was maintained
for the present analysis.
Dietary intake during the normal diet (baseline) was
recorded in a 7 d semi-weighed food diary. The data were
entered into a dietary analysis package (CompEat v4; Nutri-
tion Systems, Banbury, Oxon, UK). Intake of the formulas
during the fibre-free diet and fibre-supplemented diet was
recorded using self-reported diaries(18). Faecal frequency was
calculated from self-reported diaries during the last 7 d of
both normal diets periods (baseline), the fibre-free diet and
fibre-supplemented diet. Mean daily faecal weight was calcu-
lated from a 3 d total faecal collection during the last 3 d of
each diet period.
The final faecal specimen from each period was collected
and stored for analysis. A sample was frozen at 2808C for
analysis of SCFA using GLC, as published earlier(18).
A sample was also processed and stored for analysis of
microbiota using FISH(21). Briefly, samples were diluted
1:10 (w/v) in PBS (NaCl (8 g/l), KCl (0·2 g/l), Na2HPO4·2H2O
(1·44 g/l), KH2PO4 (0·24 g/l), pH 7·4) and fixed in 4 %
paraformaldehyde in PBS for at least 4 h. Washed cells were
re-suspended in PBS–ethanol solution (1:1, v/v) and stored
at 2208C before the present analysis.
Fluorescent in situ hybridisation
For quantification of the bacteria in these faecal samples, mul-
tiple slides with 1 cm2 wells were prepared for cell counting.
Per well, 10ml of diluted sample were spread. After drying,
the cells were fixed to the glass surface with 96 % ethanol
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for 10 min. In the present study hybridisation was performed
with an extended set of 16S rRNA-targeted probes (Table 1).
The probe set used for bacterial groups covers approximately
88 % of the total number of bacteria which hybridise with
the EUB338 probe in healthy volunteers(20). The probes
were manufactured by Eurogentec (Seraing, Belgium) and
were labelled at the 50 end with either fluorescein isothiocya-
nate (FITC) or Cy3.
The samples were hybridised overnight at 508C in hybridis-
ation buffer (0·9 M-NaCl, 20 mM-2-amino-2-hydroxymethyl-
propane-1,3-diol (Tris)-HCl (pH 7·2), 0·1 % SDS (w/v))
containing 9 ng labelled probe per slide. The slides were
washed for 20 min in wash buffer (0·9 M-NaCl, 20 mM-Tris-
HCl (pH 7·2)), rinsed briefly in Milli-Q and dried using
compressed air. Total cells were enumerated after staining
with 40,6-diamidino-2-phenylindole (DAPI). Slides were
mounted in Vectashieldw (Vector Labs, Burlingame, CA,
USA) to minimise fading of the fluorescent signal.
The fluorescent cells in the samples were counted auto-
matically with a Leicaw DMRA2 epifluorescence microscope
using a modified version of the Leicaw Q-winw software
(Leica, Wetzlar, Germany)(22). The detection limit used with
this method was set at 106 cells/g.
Concentrations are presented per g dry faeces in order to
standardise comparisons between samples with different
water content. Dry faecal weight was calculated following
lyophilisation of duplicate faecal samples.
Statistics
All data were analysed on SPSS for Windows (version 15.0;
SPSS, Inc., Chicago, IL, USA). The concentrations of faecal
bacteria were log transformed in order to have a normal distri-
bution, and the geometric mean calculated. The log-trans-
formed concentrations and proportions of bacteria were
compared between baseline and diet periods using a paired
t test. To investigate associations between the microbiota
and SCFA, the correlation between the proportion of each
bacterial group (as percentage of the total cell count) and
the proportion of each major SCFA (as percentage of the
total) was calculated using a Pearson’s correlation coefficient
at each time point. To investigate the impact of excluding and
supplementing fibre on the associations between the micro-
biota and SCFA, the change in the proportion of each bacterial
group and the change in the proportion of each major SCFA
between baseline and diet period was calculated. Then, the
correlation between the change in the proportion of each of
these was calculated using a Pearson’s correlation coefficient.
P,0·05 was considered statistically significant.
Results
Fourteen healthy subjects, five men and nine women, aged
between 21 and 34 years old were included in the original
study(18). Two women withdrew because they were unable
to consume the formula as their sole source of nutrition; one
woman withdrew because of personal reasons unrelated to
the study. One man was excluded after testing positive for
Giardia lamblia during the study. In total, ten healthy subjects
(six women and four men) completed the study and were
included in this analysis.
Intakes of fibre (19·6 and 18·0 g/d) and NSP (14·3 and
12·8 g/d) during normal (baseline) diets are similar to values
previously recorded in the UK (Table 2).
There was a reduction in faecal frequency between
the normal diet and the fibre-free diet (1·0 (SD 0·3) v. 0·6
(SD 0·2); P¼0·001), whilst the reduction between the normal
diet and the fibre-supplemented diet (1·1 (SD 0·3) v. 0·9
(SD 0·3); P¼0·056) did not reach statistical significance.
Faecal frequency was higher during the fibre-supplemented
diet than the fibre-free diet (P¼0·019). There was a reduction
in daily faecal weight between the normal diet and the fibre-
free diet (132·4 (SD 68·5) v. 43·8 (SD 30·1) g; P¼0·005) and
the normal diet and the fibre-supplemented diet (127·5
(SD 71·2) v. 73·2 (SD 37·5) g; P¼0·034). However, there
were no differences in daily faecal weight between the fibre-
free and fibre-supplemented diets (P¼0·149).
In general, the results show a declining trend in all bacterial
species during both diet periods, except for bifidobacteria,
which increased during the fibre-supplemented diet (Table 3).
Interestingly, statistically significant and large reductions in
both the concentration and the proportion of the F. prausnitzii
group and Roseburia intestinalis group occurred during
both diet periods, irrespective of fibre content, whereas
the Bacteroides group underwent significant decline in
concentration and proportion only during the fibre-free diet
period only.
There were significant reductions in concentrations of
total SCFA and each of the major SCFA (acetate, propionate,
butyrate) following the fibre-free diet, whilst only butyrate
Table 1. Probes used for the detection of the intestinal microbiota
Target Probe Label Sequence Reference
All bacteria EUB338 FITC 50GCTGCCTCCCGTAGGAGT Amann et al. (1990)(35)
Bacteroides/Prevotella Bac303 FITC 50CCAATGTGGGGGACCTT Manz et al. (1996)(36)





Hold et al. (2003)(37)
Aminov et al. (2006)(26)
Faecalibacterium prausnitzii group Fprau645 Cy3 50CCTCTGCACTACTCAAGAAAAAC Suau et al. (2001)(38)
Atopobium group Ato291 FITC 50GGTCGGTCTCTCAACCC Harmsen et al. (2000)(39)







Harmsen et al. (2002)(20)
Enterobacteriaceae EC1531 Cy3 50CACCGTAGTGCCTCGTCATCA Poulsen et al. (1994)(41)
FITC, fluorescein isothiocyanate.
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was reduced following the fibre-supplemented diet. There
was an increase in the proportion of acetate and a reduction
in the proportion of butyrate following both the fibre-free
diet and the fibre-supplemented diet. Details of these results
are presented elsewhere(18).
There were significant and strong positive correlations
between the proportion of F. prausnitzii and the proportion
of butyrate during the normal diet (Table 4) and these
occurred before both the fibre-free (r 0·881; P¼0·001) and
the fibre-supplemented diet (r 0·844; P¼0·002). Interestingly,
these correlations were no longer found during either the
fibre-free (r 0·359; P¼0·308) or the fibre-supplemented diet
(r 0·090; P¼0·805).
The dynamic effects of switching from a normal diet to a
fibre-free or a fibre-supplemented diet were also investigated
(Table 5). There was a significant correlation between the
change in proportion of F. prausnitzii and the change in
proportion of butyrate following the fibre-free diet (r 0·806;
P¼0·005) and between the change in proportion of acetate
(r 0·671; P¼0·034) and butyrate (r 0·749; P¼0·013)
following the fibre-supplemented diet. There were no other
significant correlations in these changes for any bacterial
group and any SCFA.
Discussion
This is the first study to demonstrate a strong corre-
lation between F. prausnitzii and butyrate production in
healthy volunteers during a normal diet, and that the reduc-
tion in F. prausnitzii when switching to a fibre-free or
Table 2. Nutrient intake during the consumption of normal diet (baseline), fibre-free diet and fibre-supplemented diet*
(Mean values and standard deviations)
Normal diet (baseline) Fibre-free diet Normal diet (baseline) Fibre-supplemented diet
Nutrient Mean SD Mean SD Mean SD Mean SD
Energy (kJ/d) 9540 2146 8437 1365 9193 2093 7772 1229
Protein (g/d) 84·3 27·7 80·7 13·0 77·8 21·2 74·5 11·8
Fat (g/d) 87·6 27·4 76·6 12·4 85·0 34·3 70·1 11·2
Carbohydrate (g/d) 271·0 53·9 254·7 41·2 245·9 49·5 235·0 37·2
Fibre (g/d)
Total fibre 19·6 5·3 0·0 18·0 7·7 27·9 4·4
NSP (excluding FOS) 14·3 4·2 0·0 12·8 5·2 †
FOS † 0·0 † 9·3 1·5
Soluble component † 0·0 † 13·4 2·1
Insoluble component † 0·0 † 14·5 2·3
FOS, fructo-oligosaccharides.
* Values for the energy, macronutrient and fibre content of the fibre-free diet (Nutren 1·0) and the fibre supplemented diet (Nutren fibre) were provided by Nestle´ UK.
† Data not available.
Table 3. Intestinal microbiota during the consumption of the fibre-free and fibre-supplemented diet









Mean SD Mean SD P * Mean SD Mean SD P * P †
Bacteria concentration (log10 cells/g dry faeces)
Total cell count 11·1 0·2 10·9 0·2 0·07 11·1 0·2 10·8 0·4 0·11 0·56
Total bacteria 11·0 0·1 10·8 0·2 0·07 11·0 0·3 10·9 0·3 0·45 0·50
Bacteroides 10·5 0·2 9·7 0·8 0·02 10·4 0·6 9·9 0·9 0·21 0·54
Eubacterium rectale group 10·3 0·2 9·8 0·7 0·12 10·3 0·4 9·8 0·7 0·08 0·94
Roseburia group 9·2 0·3 8·1 0·9 0·01 9·2 0·3 8·2 0·6 ,0·01 0·74
Faecalibacterium prausnitzii group 10·1 0·4 8·9 0·7 ,0·01 10·1 0·4 9·2 0·7 0·01 0·23
Atopobium group 9·3 0·8 9·3 0·7 0·98 9·2 0·7 9·2 0·9 0·96 0·35
Bifidobacteria 9·2 0·9 9·1 1·3 0·52 9·4 0·6 9·8 0·9 0·15 0·04
Ruminococci 9·9 0·3 9·2 0·8 0·05 9·7 0·8 9·4 0·5 0·15 0·34
Enterobacteriaceae 7·7 0·7 7·3 0·9 0·04 7·4 0·6 7·1 0·4 0·14 0·48
Bacteria proportion (% of total cell count)
Bacteroides 31·2 20·8 17·5 19·9 0·02 29·8 25·7 24·7 19·0 0·58 0·31
Eubacterium rectale group 20·2 14·0 19·9 22·8 0·97 26·1 37·5 12·1 7·6 0·28 0·26
Roseburia group 1·6 0·9 0·5 0·6 0·02 1·9 1·7 0·6 0·8 0·03 0·84
Faecalibacterium prausnitzii group 17·1 22·7 2·5 4·2 0·04 14·0 13·6 3·3 3·1 0·02 0·48
Atopobium group 3·7 4·2 5·9 5·8 0·35 2·4 2·4 8·8 11·0 0·05 0·26
Bifidobacteria 4·7 5·5 10·6 21·2 0·29 4·6 4·1 20·1 18·3 0·01 0·07
Ruminococci 7·1 3·2 5·9 7·9 0·67 8·2 7·9 6·6 7·3 0·63 0·80
Enterobacteriaceae 0·1 0·1 0·1 0·2 0·42 0·0 0·0 0·0 0·1 0·57 0·19
*P value for diet v. baseline.
†P value for fibre-free diet v. fibre-supplemented diet.


















Downloaded from https://www.cambridge.org/core. Rijksuniversiteit Groningen, on 08 Nov 2018 at 14:33:53, subject to the Cambridge Core terms of use, available at
fibre-supplemented liquid diet also correlates with the
reduction in faecal butyrate. Duncan et al. have previously
shown a correlation between Roseburia and butyrate pro-
duction in obese patients on a carbohydrate-restricted diet;
however, in that study the correlation with F. prausnitzii
was poor(23).
We describe an in-depth analysis of faecal samples from a
study of healthy subjects consuming defined liquid diets either
devoid of fibre or fibre-supplemented. In the previous
report(18), SCFA were measured in the stool samples and all
major SCFA (acetate, propionate, butyrate) were reduced
following a fibre-free diet, whereas following a fibre-
supplemented diet acetate and propionate did not significantly
decrease from baseline, whilst butyrate did. However, without
the present analysis, and in particular the detection of the
decrease in F. prausnitzii during both diets, the reduction in
butyrate during both diets would have remained unex-
plained(24). Although there were also correlations between
butyrate and other species, only in F. prausnitzii did the
correlation occur in both baseline diets and in the
dynamic effects analysis. The results for FISH analysis were
remarkably reproducible, with bacterial counts similar to the
original analysis following long-term storage in ethanol–
PBS at 2208C. The present analysis used automated,
rather than manual, counting and this may explain the
subtle differences in results found here compared with the
previous analysis.
There was an increase in proportion of bifidobacteria during
the fibre-containing diet, which contained prebiotic fructo-
oligosaccharides. This may explain why acetate concen-
trations were higher compared with during the fibre-free
diet, as bifidobacteria are major producers of acetate(18).
Other bacteria responsible for butyrate production, such as
Roseburia spp., are associated with insoluble fibres and fer-
ment these as an energy source(25). In addition, ruminococci
also attach to dietary fibres(26) and these bacteria also show
a trend towards lower numbers during both fibre-free and
fibre-supplemented diets.
Table 4. Correlations between the proportion of intestinal microbiota (as percentage of total cells) and the
proportion of acetate, propionate and butyrate (as percentage of total SCFA) at the end of each dietary period
Acetate Propionate Butyrate
r P r P r P
Bacteroides
Normal diet (baseline) 20·470 0·170 0·443 0·200 0·202 0·575
Fibre-free diet 20·548 0·101 0·910 ,0·001* 0·401 0·251
Normal diet (baseline) 20·208 0·563 0·118 0·746 20·141 0·698
Fibre-supplemented diet 0·008 0·983 0·365 0·300 0·043 0·907
Eubacterium rectale group
Normal diet (baseline) 20·513 0·129 20·138 0·703 0·950 ,0·001*
Fibre-free diet 20·321 0·365 0·367 0·297 0·171 0·636
Normal diet (baseline) 0·192 0·596 20·313 0·379 0·502 0·139
Fibre-supplemented diet 0·004 0·992 0·469 0·172 0·076 0·835
Faecalibacterium prausnitzii group
Normal diet (baseline) 20·498 0·143 0·021 0·954 0·881 0·001*
Fibre-free diet 20·365 0·299 0·351 0·319 0·359 0·308
Normal diet (baseline) 0·393 0·261 20·510 0·132 0·844 0·002*
Fibre-supplemented diet 20·374 0·286 0·594 0·070 0·090 0·805
Atopobium group
Normal diet (baseline) 0·415 0·233 20·238 0·5074 20·327 0·356
Fibre-free diet 20·077 0·833 20·130 0·720 0·189 0·601
Normal diet (baseline) 20·090 0·805 0·125 0·730 20·246 0·492
Fibre-supplemented diet 0·180 0·619 20·640 0·046* 0·273 0·445
Bifidobacteria
Normal diet (baseline) 20·286 0·424 0·258 0·471 0·070 0·848
Fibre-free diet 0·486 0·155 20·400 0·252 20·160 0·659
Normal diet (baseline) 20·371 0·291 0·263 0·463 0·206 0·568
Fibre-supplemented diet 0·264 0·460 20·255 0·477 20·127 0·726
Ruminococci
Normal diet (baseline) 0·146 0·688 20·536 0·111 0·051 0·889
Fibre-free diet 20·609 0·062 0·422 0·225 0·665 0·036*
Normal diet (baseline) 0·362 0·304 20·485 0·155 0·546 0·102
Fibre-supplemented diet 0·361 0·305 20·132 0·717 0·003 0·994
Roseburia intestinalis group
Normal diet (baseline) 20·600 0·067 0·289 0·417 0·307 0·389
Fibre-free diet 20·503 0·139 0·284 0·426 0·284 0·427
Normal diet (baseline) 20·283 0·429 0·147 0·686 0·266 0·458
Fibre-supplemented diet 20·125 0·731 0·103 0·777 0·084 0·818
Enterobacteriaceae
Normal diet (baseline) 0·398 0·255 20·004 0·991 20·171 0·637
Fibre-free diet 20·073 0·841 0·138 0·704 20·165 0·649
Normal diet (baseline) 0·259 0·470 20·340 0·337 0·670 0·034*
Fibre-supplemented diet 20·179 0·621 20·117 0·747 20·070 0·847
* P,0·05.
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We speculate that the inability of the fibre-supplemented
formula to fully maintain the original microbiota might be
related to the composition of the insoluble fibres contained
within the liquid enteral formula. The fibre-supplemented
formula contained 48 % soluble and 52 % insoluble fractions
from fructo-oligosaccharides and pea fibre, and it has been
shown that different sources of dietary fibre lead to the
formation of different SCFA profiles(27). In pea fibres the
strong linkages between uronic acid and xylose protect
the xylose from fermentation, whereas in wheat-bran fibres
the majority of the xylose molecules are ordered in linear
xylans which are preferentially degraded. The fermentation
of xylose provides a preferential substrate for the production
of butyrate; therefore wheat-bran fibre leads to a higher
production of butyrate than pea fibre(27). Whilst the reduction
in Roseburia spp. and F. prausnitzii during the fibre-free diet
may be caused by the absence of fibre, their reduction during
the fibre-supplemented diet may relate to the presence of a
fibre that does not support proliferation of Roseburia and
F. prausnitzii. A recent study showed that inulin increased
the numbers of both bifidobacteria and F. prausnitzii (28).
However, we cannot confirm this increase in F. prausnitzii
with the data from the present study.
There was a reduction in faecal weight and frequency
during both liquid diet regimens. This, together with the
lower concentrations of bacteria and SCFA, reflects an even
larger fall in total amounts of bacteria and SCFA. As none
of the volunteers reported diarrhoea, a common complication
of enteral nutrition, this is not a cause of the reduction in
F. prausnitzii in these samples(29).
Reduction of the butyrate-producing capacity of the micro-
biota is likely to be important in both health and in specific
disease states. Low amounts of this primary energy source
for the colonocytes may result in decreased intestinal barrier
integrity. Furthermore, abnormal water excretion in the
colon has been observed during enteral feeding which prob-
ably contributes to the pathogenesis of diarrhoea(30). This
effect has been shown to be reversed when supplementing
SCFA, including butyrate, to the colon(3). A case study on
antibiotic-induced diarrhoea supports the concept that lowered
levels of SCFA coincide with the occurrence of diarrhoea(31).
In a recent study on the microbiota of patients with Crohn’s
disease, those who were still in remission 6 months after
surgery were found to have higher mucosal concentrations
of F. prausnitzii compared with those who had relapsed(32).
Meanwhile, patients with active inflammatory bowel disease
have lower faecal concentrations of F. prausnitzii than healthy
controls(15). Studies have demonstrated that this bacterial
strain has pronounced immunoregulatory effects. These
include decreased IL-12 and interferon-g and increased
IL-10 production in peripheral blood mononuclear cells, and
marked improvement in inflammation in a murine model of
colitis(32). A significant reduction in F. prausnitzii, as shown
in the present study, might therefore potentially lead to
an increased inflammation and disease activity in Crohn’s
disease.
Whilst the present analysis relates to luminal, not mucosal,
microbiota the present results seem somewhat paradoxical,
as we have shown that enteral formulas cause a reduction in
F. prausnitzii, despite the fact that they are used as primary
Table 5. Correlation between the change in proportion of intestinal microbiota (as percentage of total cells) and
the change in the proportion of acetate, propionate and butyrate (as percentage of total SCFA) between the
standard diet (baseline) and a fibre-free or a fibre-supplemented diet
Change in SCFA
Acetate Propionate Butyrate
Change in microbiota r P r P r P
Bacteroides
Baseline to fibre-free diet 20·489 0·151 0·272 0·448 0·597 0·069
Baseline to fibre-supplemented diet 20·041 0·909 0·185 0·609 0·015 0·967
Eubacterium rectale group
Baseline to fibre-free diet 20·358 0·309 0·209 0·563 0·128 0·724
Baseline to fibre-supplemented diet 0·118 0·746 20·113 0·755 0·519 0·124
Faecalibacterium prausnitzii group
Baseline to fibre-free diet 20·103 0·777 20·106 0·771 0·806 0·005*
Baseline to fibre-supplemented diet 0·671 0·034* 20·603 0·065 0·749 0·013*
Atopobium group
Baseline to fibre-free diet 20·071 0·845 0·162 0·654 0·323 0·362
Baseline to fibre-supplemented diet 0·175 0·629 20·479 0·161 0·243 0·499
Bifidobacteria
Baseline to fibre-free diet 0·408 0·242 20·296 0·407 20·320 0·368
Baseline to fibre-supplemented diet 0·091 0·803 0·067 0·854 20·486 0·155
Ruminococci
Baseline to fibre-free diet 20·392 0·263 0·526 0·119 20·277 0·439
Baseline to fibre-supplemented diet 0·245 0·495 20·202 0·575 0·539 0·108
Roseburia intestinalis group
Baseline to fibre-free diet 20·404 0·247 0·268 0·454 20·121 0·739
Baseline to fibre-supplemented diet 0·147 0·685 20·099 0·786 0·264 0·462
Enterobacteriaceae
Baseline to fibre-free diet 20·332 0·348 0·489 0·152 0·089 0·807
Baseline to fibre-supplemented diet 0·425 0·221 20·570 0·085 0·304 0·393
* P,0·05.
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treatment in active Crohn’s disease. The exact mechanism of
effect of enteral formulas in inducing remission in Crohn’s
disease is not clear, and the role of the mucosal and luminal
microbiota requires further research. The present study
suggests that this beneficial effect of enteral formula use is
probably not mediated by F. prausnitzii.
Patients with isolated colonic Crohn’s disease, who have no
ileal disease, respond poorly to treatment with enteral for-
mulas alone(33). As F. prausnitzii has been found in lower
numbers in patients with Crohn’s colitis(15), our present results
might provide an explanation why patients with isolated colo-
nic Crohn’s disease do not respond well to treatment with only
enteral formulas, in contrast to patients with isolated ileal
Crohn’s disease. The mechanisms necessary for inducing
remission probably differ for the different disease states and
localisation of Crohn’s disease. Whereas microbial debulking
might prove beneficial in ileal Crohn’s disease, the coinciding
depletion of colonic F. prausnitzii might not be beneficial in
isolated colonic Crohn’s disease. What is of striking relevance
is the positive association between F. prausnitzii and butyrate
production in the gastrointestinal tract, especially since buty-
rate may be therapeutic for active ulcerative colitis and
Crohn’s disease(34). More studies of the effect of enteral for-
mulas on the microbiota and SCFA, in particular F. prausnitzii
and butyrate, are required in Crohn’s disease.
For future research it is important to include an extensive
probe set when investigating effects of the intestinal micro-
biota on SFCA production with FISH. Furthermore, alterna-
tive fibre supplements should be designed to restore the
numbers of butyrate-producing bacteria and concentrations
of butyrate in the faecal samples; these should be investigated
for use in enteral formulas.
Conclusion
We have shown that a diet either devoid of fibre, or a diet sup-
plemented with dietary fibre wherein pea fibre constitutes the
main insoluble fraction, is accompanied by lower numbers of
bacteria from the F. prausnitzii and Roseburia groups. The
decrease of bacteria from the F. prausnitzii group is correlated
with lower concentrations of faecal butyrate.
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